These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23224461)

  • 21. Neuroleptic Malignant Syndrome Induced by Olanzapine in a Patient with Huntington's Disease.
    Moreno JL; Palau Fayos JM; Díaz de Santiago A; García de Yébenes J
    J Huntingtons Dis; 2012; 1(1):31-2. PubMed ID: 25063189
    [No Abstract]   [Full Text] [Related]  

  • 22. [Life threatening neuroleptic malignant syndrome due to olanzapine].
    Kopf A; Köster J; Schulz A; Krömker H; Becker T
    Psychiatr Prax; 2003 Jul; 30(5):279-82. PubMed ID: 12872187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unexpected hospitalisation side effects in an elderly man.
    Leone MC; Chiussi G; Pigna F; Baroni MC; Delsignore R
    Intern Emerg Med; 2011 Apr; 6(2):187-8. PubMed ID: 20458555
    [No Abstract]   [Full Text] [Related]  

  • 24. Late-onset neuroleptic malignant syndrome in a patient using olanzapine.
    Kunz M; Gomes FA; Tramontina JF; Kapczinski F
    J Clin Psychopharmacol; 2007 Jun; 27(3):303-4. PubMed ID: 17502780
    [No Abstract]   [Full Text] [Related]  

  • 25. [Association of atypical neuroleptics with anticonvulsants and malignant syndrome. Report of 2 cases].
    Nabih FO; Benali A; Adali I; Manoudi F; Asri F
    Pan Afr Med J; 2014; 18():220. PubMed ID: 25422695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome.
    Lee JW
    J Clin Psychopharmacol; 2010 Feb; 30(1):3-10. PubMed ID: 20075641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olanzapine induced neuroleptic malignant syndrome--a case review.
    Kogoj A; Velikonja I
    Hum Psychopharmacol; 2003 Jun; 18(4):301-9. PubMed ID: 12766935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Electroconvulsion therapy for neuroleptic malignant syndrome].
    Buggenhout S; Vandenberghe J; Sienaert P
    Tijdschr Psychiatr; 2014; 56(9):612-5. PubMed ID: 25222100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL; Taylor WH; Ware MR
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.
    Aarsland D; Perry R; Larsen JP; McKeith IG; O'Brien JT; Perry EK; Burn D; Ballard CG
    J Clin Psychiatry; 2005 May; 66(5):633-7. PubMed ID: 15889951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroleptic malignant syndrome induced by metoclopramide in an infant with Freeman-Sheldon syndrome.
    Stein MH; Sorscher M; Caroff SN
    Anesth Analg; 2006 Sep; 103(3):786-7. PubMed ID: 16931708
    [No Abstract]   [Full Text] [Related]  

  • 32. Comments on the report of neuroleptic malignant syndrome induced by ziprasidone.
    Margetic B; Aukst-Margetic B
    World J Biol Psychiatry; 2007; 8(2):131-2; author reply 133-4. PubMed ID: 17455107
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
    Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M
    W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptic malignant syndrome in a patient on long-term olanzapine treatment at a stable dose: Successful treatment with dantrolene.
    Kouparanis A; Bozikas A; Spilioti M; Tziomalos K
    Brain Inj; 2015; 29(5):658-60. PubMed ID: 25625410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant catatonia in a patient with bipolar disorder, B12 deficiency, and neuroleptic malignant syndrome: one cause or three?
    Lewis AL; Pelic C; Kahn DA
    J Psychiatr Pract; 2009 Sep; 15(5):415-22. PubMed ID: 19820558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lewy body dementia.
    Baldwin SH; Avery E
    J Miss State Med Assoc; 2002 Apr; 43(4):107-8. PubMed ID: 11989189
    [No Abstract]   [Full Text] [Related]  

  • 37. Atypical neuroleptic malignant syndrome in an adolescent.
    Rais AR; Kimmel S; Shrestha N; Rais TB; Coffey BJ
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):215-20. PubMed ID: 18439120
    [No Abstract]   [Full Text] [Related]  

  • 38. Series of seizures as a sign of development of recurrent malignant neuroleptic syndrome - a case report.
    Supe S; Matijević V; Kondić L; Alvir D
    Psychiatr Danub; 2006 Jun; 18(1-2):97-101. PubMed ID: 16804507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical neuroleptic malignant syndrome caused by olanzapine.
    Nielsen J; Bruhn AM
    Acta Psychiatr Scand; 2005 Sep; 112(3):238-40; discussion 240. PubMed ID: 16095481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Olanzapine associated weight gain, hyperglycemia and neuroleptic malignant syndrome: case report.
    Malyuk R; Gibson B; Procyshyn RM; Kang N
    Int J Geriatr Psychiatry; 2002 Apr; 17(4):326-8. PubMed ID: 11994885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.